CAC
XGN icon

Cowen and Company’s Exagen XGN Stock Holding History

Cowen and Company’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-891,366
Closed -$2.75M – 313
2024
Q3 		$2.75M Hold
891,366
– – 0.09% 92
2024
Q2 		$1.62M Sell
891,366
-7,264
-0.8% -$12.3K 0.04% 131
2024
Q1 		$1.43M Hold
898,630
– – 0.06% 135
2023
Q4 		$1.79M Buy
898,630
+56,254
+7% +$97.3K 0.12% 121
2023
Q3 		$2.06M Hold
842,376
– – 0.14% 109
2023
Q2 		$2.44M Sell
842,376
-101,176
-11% -$288K 0.2% 86
2023
Q1 		$2.29M Sell
943,552
-22,470
-2% -$58.1K 0.27% 54
2022
Q4 		$2.32M Sell
966,022
-363,361
-27% -$932K 0.24% 56
2022
Q3 		$3.6M Sell
1,329,383
-26,031
-2% -$145K 0.34% 43
2022
Q2 		$7.78M Sell
1,355,414
-29,217
-2% -$170K 0.75% 33
2022
Q1 		$11.1M Hold
1,384,631
– – 1.07% 26
2021
Q4 		$16.1M Hold
1,384,631
– – 1.46% 16
2021
Q3 		$18.8M Buy
1,384,631
+658,553
+91% +$8.75M 0.89% 22
2021
Q2 		$10.9M Buy
726,078
+274,257
+61% +$4.21M 0.57% 29
2021
Q1 		$7.91M Buy
451,821
+135,271
+43% +$2.41M 0.54% 21
2020
Q4 		$4.18M Buy
316,550
+23,211
+8% +$328K 0.37% 28
2020
Q3 		$3.18M Sell
293,339
-139,063
-32% -$1.79M 0.52% 33
2020
Q2 		$5.37M Buy
432,402
+192,731
+80% +$2.61M 0.89% 14
2020
Q1 		$3.82M Buy
+239,671
New +$4.76M 0.88% 22

Other funds holding XGN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cowen and Company's XGN Position: Q4 2024 in Review

Cowen and Company sold out of Exagen (XGN) in Q4 2024, closing a stake of 891,366 shares — an estimated $2.75M sold.

Cowen and Company first reported a position in XGN in Q1 2020 and held it in 19 quarters. The position peaked at $18.8M in Q3 2021. 41 funds tracked by Wall St. Rank hold XGN as of Q4 2024.

  • Cowen and Company reported no remaining Exagen position as of Q4 2024 after selling out during the quarter.
  • Cowen and Company sold 891,366 Exagen shares in Q4 2024, an estimated $2.75M.
  • Cowen and Company first reported a position in Exagen in Q1 2020 and held it in 19 quarters.
  • Cowen and Company's Exagen position peaked at $18.8M in Q3 2021.
  • 41 funds tracked by Wall St. Rank held Exagen as of Q4 2024.

Based on Cowen and Company's 13F filing for Q4 2024.